« Previous
Next »
Titles
- Health document submission requirements for tobacco products: (revised)1
- Hematologic malignancies: regulatory considerations for use of minimal residual disease in development of drug and biological products for treatment1
- Hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia: developing drugs for treatment1
- How to prepare a pre-request for designation (pre-RFD)1
- Human gene therapy for hemophilia1
- Human gene therapy for rare diseases1
- Human gene therapy for retinal disorders1
- Human immunodeficiency virus-1 infection: developing systemic drug products for pre-exposure prophylaxis1
- Humanitarian device exemption (HDE) program: guidance for industry and Food and Drug Administration staff1